Aquilion Serve (TSX-307A/1) V1.3

The Aquilion Serve (TSX-307A/1) V1.3 is a whole-body CT scanner that leverages multi-slice helical acquisition, AiCE deep learning-based image reconstruction for noise reduction, and a SilverBeam Filter for radiation dose optimization. This system aims to provide enhanced diagnostic imaging through improved image quality, new scanning capabilities like dynamic and dual-energy modes, and increased operational efficiency via features such as Anatomical Landmark Detection.

The Aquilion Serve (TSX-307A/1) V1.3 is a whole-body multi-slice helical Computed Tomography (CT) X-ray system designed to acquire and display cross-sectional volume data sets of the entire body, including the head, for specialized diagnostic studies. Its core technology includes the AiCE (Advanced Intelligent Clear-IQ Engine), a noise reduction algorithm employing Deep Convolutional Neural Network methods to enhance image quality in applications spanning the abdomen, pelvis, lung, cardiac, extremities, head, and inner ear. This version introduces several key modifications: a 'Dynamic scan' mode for continuous scanning of a target region, an optional dual-energy scanning system for improved material differentiation, an optional extended field of view (up to 800mm), and an exposure reduction mode featuring the SilverBeam Filter aimed at minimizing radiation dose while preserving image integrity. Performance evaluations demonstrated the efficacy of these enhancements. Phantom studies confirmed that the SilverBeam Filter, used in conjunction with AiCE, provided equivalent or improved image quality (assessed by noise levels and visual inspection for artifacts) while achieving a reduction in radiation dose for head and body scans. Workflow assessments focusing on non-contrast chest and chest-to-abdomen scans revealed that the integration of Anatomical Landmark Detection (ALD) resulted in a 24% reduction in scan planning time, fewer operator clicks, and more consistent scan setups. The system also incorporates software developed to a moderate level of concern and addresses cybersecurity considerations, with overall testing verifying that the device meets its established specifications for its intended clinical use by trained physicians.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What is the quantifiable range of dose reduction achieved by the SilverBeam Filter in conjunction with AiCE across different anatomical regions and patient demographics?; How does the 'Dynamic scan' mode's continuous scanning capability improve temporal resolution and reduce motion artifacts in challenging applications like pediatric or cardiac imaging compared to conventional techniques?; What are the specific material decomposition capabilities and quantitative accuracy of the optional dual-energy system, and how does it enhance diagnostic information for conditions like gout or kidney stone characterization?; Beyond chest and chest-to-abdomen scans, what is the potential for Anatomical Landmark Detection (ALD) to automate and standardize scan planning in other complex anatomical regions or for specific clinical protocols?; What are the detailed performance metrics (e.g., contrast-to-noise ratio, spatial resolution, low-contrast detectability) that substantiate the 'equivalent or improved image quality' claim for AiCE when combined with the SilverBeam filter, particularly at reduced dose levels?